included primarily breast cancer patients, reporting baseline AMH levels of 15.4 ± 17.2 pmol/l (25), which converts to 2.16 ± 2.41 ng/ml using the standardized conversion factor (1 pmol/l ≈ 0.14 ng/ml). The gene discussed is AMH; the disease is breast carcinoma.